Page last updated: 2024-12-09
tinopal cbs-x
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
4,4'-bis(2-sulfostyryl)biphenyl: a stilbene-type fluorescent whitening agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Tinopal CBS-X: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6434006 |
| SCHEMBL ID | 1502467 |
| MeSH ID | M0158877 |
| PubMed CID | 5332133 |
| SCHEMBL ID | 15769461 |
| MeSH ID | M0158877 |
Synonyms (54)
| Synonym |
|---|
| disodium 4,4'-bis-((4-anilino-6-(n-methyl-2-hydroxyethylamino)-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulfonate |
| tinopal cbs |
| fba 351 |
| stilbene 3 |
| einecs 248-421-0 |
| benzenesulfonic acid, 2,2'-((1,1'-biphenyl)-4,4'-diyldi-2,1-ethenediyl)bis-, disodium salt |
| benzenesulfonic acid, 2,2'-(4,4'-biphenylylenedivinylene)di-, disodium salt |
| disodium 2,2'-((1,1'-biphenyl)-4,4'-diyldivinylene)bis(benzenesulphonate) |
| 4,4'-bis(2-sulfostyryl)biphenyl |
| 81g7704myr , |
| unii-81g7704myr |
| ec 248-421-0 |
| benzenesulfonic acid, 2,2'-((1,1'-biphenyl)-4,4'-diyldi-2,1-ethenediyl)bis-, sodium salt (1:2) |
| SCHEMBL1502467 |
| unii-i25r28r1yg |
| 60317-04-6 |
| disodium 4,4'-bis(2-sulfostyryl)biphenyl, (z,z)- |
| disodium distyrylbiphenyl disulfonate, (z,z)- |
| i25r28r1yg , |
| benzenesulfonic acid, 2,2'-((1,1'-biphenyl)-4,4'-diyldi-2,1-ethenediyl)bis-, disodium salt, (z,z)- |
| Q2816661 |
| (z,z)-disodium distyrylbiphenyl disulfonate |
| tinopal cbs-x |
| cas-27344-41-8 |
| NCGC00255583-01 |
| dtxcid4016467 |
| tox21_301540 |
| A819028 |
| sodium 2,2'-([1,1'-biphenyl]-4,4'-diylbis(ethene-2,1-diyl))dibenzenesulfonate |
| f7992ztu7z , |
| disodium distyrylbiphenyl disulfonate, (e,e)- |
| unii-f7992ztu7z |
| 56776-28-4 |
| AKOS015856607 |
| calcofluor cg |
| SCHEMBL15769461 |
| sodium 2,2'-((1e,1'e)-[1,1'-biphenyl]-4,4'-diylbis(ethene-2,1-diyl))dibenzenesulfonate |
| FD10632 |
| disodium distyrylbiphenyl disulfonate |
| benzenesulfonic acid, 2,2'-((1,1'-biphenyl)-4,4'-diyldi-(1e)-2,1-ethenediyl)bis-, sodium salt (1:2) |
| disodium 4,4'-bis(2-sulfostyryl)biphenyl, (e,e)- |
| fluorescent brightener cbs-x |
| fluorescent brightener 351 |
| J-016745 |
| sodium 2,2'-(1e,1'e)-2,2'-(biphenyl-4,4'-diyl)bis(ethene-2,1-diyl)dibenzenesulfonate |
| AS-13917 |
| disodium;2-[(e)-2-[4-[4-[(e)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate |
| sodium2,2'-([1,1'-biphenyl]-4,4'-diylbis(ethene-2,1-diyl))dibenzenesulfonate |
| (e,e)-disodium distyrylbiphenyl disulfonate |
| Q27277762 |
| sodium 2,2'-([1,1'-biphenyl]-4,4'-diylbis-(ethene-2,1-diyl))dibenzenesulfonate |
| CS-W009601 |
| benzenesulfonic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diyldi(e)-2,1-ethenediyl]bis-, sodium salt (1:2) |
| 4,4'-bis(o-sulfostyryl)biphenyl disodium |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (21)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 57.2087 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 39.4403 | 3.1890 | 29.8841 | 59.4836 | AID1224846; AID1224894 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 44.2528 | 0.1737 | 34.3047 | 61.8120 | AID1346859; AID1347035 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 44.2528 | 0.1737 | 34.3047 | 61.8120 | AID1346859; AID1347035 |
| AR protein | Homo sapiens (human) | Potency | 29.0382 | 0.0002 | 21.2231 | 8,912.5098 | AID743035; AID743036; AID743053; AID743063 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 44.4767 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377; AID1259378; AID1259394 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 17.1642 | 0.0002 | 14.3764 | 60.0339 | AID720691; AID720692; AID720719 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 27.4591 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 32.5464 | 0.3758 | 27.4851 | 61.6524 | AID743217; AID743220; AID743239 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 38.0368 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075; AID743077; AID743078 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 27.0020 | 0.0010 | 24.5048 | 61.6448 | AID743212; AID743215; AID743227 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 34.5352 | 0.0010 | 19.4141 | 70.9645 | AID743094; AID743140; AID743191 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 35.2907 | 0.0237 | 23.2282 | 63.5986 | AID743222; AID743223; AID743241 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 45.3179 | 0.1434 | 27.6121 | 59.8106 | AID1159516; AID1159519 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 34.5690 | 19.7391 | 45.9784 | 64.9432 | AID1159509; AID1159518 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 27.1876 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 45.6123 | 0.0391 | 47.5451 | 146.8240 | AID1224845 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 43.8709 | 0.0003 | 23.4451 | 159.6830 | AID743067 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 29.6251 | 0.0420 | 27.3789 | 61.6448 | AID743210; AID743228 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 45.7207 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 25.5006 | 0.0023 | 19.5956 | 74.0614 | AID651631; AID720552 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Biological Processes (124)
Molecular Functions (34)
Ceullar Components (19)
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||